U.S. Physical Therapy stock holds steady as valuation screens show fair pricing

Published on 09/20/2026 at 13:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

U.S. Physical Therapy stock recently closed at USD 82.47 with a market value of about USD 1.3 billion as of September 19, 2026. Valuation models currently see the shares as fairly valued, offering investors a stable healthcare exposure.

USPH, US9175021020, Illustration mit AI erstellt.

U.S. Physical Therapy stock (ISIN US9175021020) recently closed at USD 82.47 on its primary U.S. exchange, giving the company a market value of about USD 1.3 billion as of September 19, 2026, according to a healthcare valuation overview by Faircurve.

Valuation snapshot for U.S. Physical Therapy

In a sector ranking updated on September 19, 2026, U.S. Physical Therapy is listed with a last close of USD 82.47 and a model fair value of USD 77.65, implying a valuation gap of negative 5.8 percent as the shares trade modestly above the internal fair value estimate, according to Faircurve.

The same table assigns U.S. Physical Therapy a quality score of 62 on its proprietary scale and reports a market value of roughly USD 1.3 billion, placing the company among mid-cap medical care facilities within the broader healthcare universe, as shown by Faircurve.

Sector context and investor takeaways

The negative 5.8 percent gap between the recent share price and the model fair value suggests that U.S. Physical Therapy stock is currently viewed as fairly valued rather than deeply discounted in this particular framework, which may appeal to investors seeking defensive healthcare exposure instead of aggressive turnaround stories, based on data from Faircurve.

Within the healthcare sector list, U.S. Physical Therapy is categorized under medical care facilities, a segment that typically benefits from recurring patient volumes and insurance reimbursement streams, and the fair-valued verdict combined with a mid-range quality score of 62 indicates a balance between business fundamentals and current pricing, according to the September 19, 2026 sector view from Faircurve.

Stock level and market perspective

With the closing price of USD 82.47 as of September 19, 2026 on its primary U.S. listing and a market capitalization near USD 1.3 billion, U.S. Physical Therapy stock currently reflects a valuation modestly above the cited USD 77.65 fair value level, highlighting a relatively tight spread between the trading price and model estimation for investors monitoring entry points.